Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1800795
PUBLISHER: IMARC | PRODUCT CODE: 1800795
Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global neurodegenerative disease treatment market size reached USD 78.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 118.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2025-2033.
Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.
The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.
Key Market Segmentation:
Breakup by Indication:
- Multiple Sclerosis
- Parkinson's Disease
- Alzheimer's Disease
- Spinal Muscular Atrophy (SMA)
- Huntington's Disease
- Others
Breakup by Drug Type:
- N-methyl-D-aspartate Receptor Antagonists
- Selective Serotonin Reuptake Inhibitors
- Dopamine Inhibitors
- Others
Breakup by Route of Administration:
- Oral
- Injectable
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.
Key Questions Answered in This Report:
- How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global neurodegenerative disease treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A3102
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurodegenerative Disease Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Multiple Sclerosis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Parkinson's Disease
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Alzheimer's Disease
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Spinal Muscular Atrophy (SMA)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Huntington's Disease
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 N-methyl-D-aspartate Receptor Antagonists
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Selective Serotonin Reuptake Inhibitors
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Dopamine Inhibitors
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Biogen
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Boehringer Ingelheim International GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 F. Hoffmann-La Roche AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 GlaxoSmithKline Plc
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 SWOT Analysis
- 15.3.5 Merck & Co. Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Novartis AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Pfizer Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Sanofi S.A
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Teva Pharmaceutical Industries Ltd.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 UCB S.A
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Biogen
Product Code: SR112025A3102
List of Figures
- Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2024
- Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2024
- Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2024
- Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2024
- Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2024
- Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2024
- Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
- Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
- Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million USD), 2025-2033
- Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
- Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.